Galecto Inc Stock Ownership - Who owns Galecto?

Insider buying vs selling

Have Galecto Inc insiders been buying or selling?
Orbimed Advisors LLC10% Owner2023-08-1538,327$0.75
Orbimed Advisors LLC10% Owner2023-08-15535,534$0.75
Orbimed Advisors LLC10% Owner2023-08-15248,819$0.75
Orbimed Advisors LLC10% Owner2023-07-31153,078$3.00
Orbimed Advisors LLC10% Owner2023-07-3126,622$3.00
Orbimed Advisors LLC10% Owner2023-07-3129,700$3.00
Orbimed Advisors LLC10% Owner2023-07-254,700$2.92
Orbimed Advisors LLC10% Owner2023-07-257,800$2.92
Orbimed Advisors LLC10% Owner2023-07-2526,700$2.92
Orbimed Advisors LLC10% Owner2023-07-1352,800$2.40

1 of 4

GLTO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GLTO insiders and whales buy or sell their stock.

GLTO Shareholders

What type of owners hold Galecto Inc stock?
Orbimed Advisors LLC9.38%2,542,186$1.51MInsider
Holdings A. Novo9.21%2,497,791$1.49MInsider
Novo Holdings A9.21%2,497,791$1.49MInstitution
Chau Quang Khuong3.81%1,031,811$613.93kInsider
Orbimed Advisors LLC3.41%924,788$550.25kInstitution
Soleus Capital Management LP3.31%897,657$534.11kInstitution
Stephan Christgau2.01%546,136$324.95kInsider
Vanguard Group Inc0.80%217,300$129.29kInstitution
Geode Capital Management LLC0.77%208,333$123.96kInstitution
Renaissance Technologies LLC0.76%205,100$122.03kInstitution

1 of 3

GLTO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GLTO20.09%24.86%Net Selling
FBRX45.96%21.83%Net BuyingNet Selling
TARA13.79%86.21%Net Selling

Galecto Stock Ownership FAQ

Who owns Galecto?

Galecto (NASDAQ: GLTO) is owned by 20.09% institutional shareholders, 24.86% Galecto insiders, and 55.05% retail investors. Orbimed Advisors LLC is the largest individual Galecto shareholder, owning 2.54M shares representing 9.38% of the company. Orbimed Advisors LLC's Galecto shares are currently valued at $1.60M.

If you're new to stock investing, here's how to buy Galecto stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.